Dec 16 (Reuters) - Biomerica Inc BMRA.O :
* BIOMERICA ANNOUNCES PRELIMINARY SECOND QUARTER REVENUE
INCREASE
OF APPROXIMATELY 238%, TO APPROXIMATELY $4.6 MILLION
* SEES Q2 REVENUE ABOUT $4.6 MILLION
* FOR Q2 ENDED NOVEMBER 30, 2021, COMPANY ALSO EXPECTS TO
REPORT
AN OPERATING LOSS OF BETWEEN $0.9 MILLION AND $1.3 MILLION.
* EXPERIENCED LOGISTICS CONSTRAINTS AND SIGNIFICANTLY HIGHER
SHIPPING COSTS WHICH HAD A MATERIAL NEGATIVE IMPACT
* INFOODS IBS CLINICAL TRIAL ON TRACK FOR COMPLETION IN
DECEMBER
Source text for Eikon: ID:nGNXbdM9sB
Further company coverage: BMRA.O
((Reuters.Briefs@thomsonreuters.com;))